Patent · US Active

Compositions comprising an anti-C5 antibody

US10125191B2 · kind B2 · utility

4Cited by
21References
6Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 11, 2017
Grant dateNov 13, 2018
Priority date
Expiry dateAug 11, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to methods and compositions employing an antibody that inhibits activation of the complement system and can be used to prevent or treat a pulmonary disease or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.